4.3 Article

Liver Transplant for Intrahepatic Cholangiocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

Christopher L. Bowlus et al.

HEPATOLOGY (2023)

Article Surgery

Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma

Robert R. McMillan et al.

Summary: Intrahepatic cholangiocarcinoma (iCCA) has traditionally been considered a contraindication for liver transplantation (LT), but recent studies have shown positive outcomes for LT after neoadjuvant therapy. A center developed a protocol for neoadjuvant therapy and LT for locally advanced, unresectable iCCA patients in 2010. Patients who underwent LT had a high overall survival rate at 1, 3, and 5 years, with a higher than expected proportion of patients with genetic alterations in fibroblast growth factor receptor (FGFR) and DNA damage repair pathways. Further research is needed to determine criteria for LT in iCCA and factors predicting survival.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Review Gastroenterology & Hepatology

Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?

Gonzalo Sapisochin et al.

Summary: Cholangiocarcinoma is the second-most common primary liver malignancy. Liver transplantation can be considered for intrahepatic and extrahepatic cholangiocarcinoma in select patients based on disease stage and patient characteristics.

HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Expanding indications for liver transplantation in the era of liver transplant oncology

Guergana Panayotova et al.

Summary: Despite advances in liver transplantation for certain malignancies such as hepatocellular carcinoma and hilar cholangiocarcinoma, the application of liver transplantation in the setting of gastrointestinal malignancies remains controversial. Tumor biology and response to therapy are key factors for optimal oncologic outcomes, while patient and tumor selection protocols are necessary for successful outcomes. Further investigation is needed to determine the expanded role of liver transplantation in malignancy in a new era of liver transplant oncology.

WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Surgery

New Breakthroughs for Liver Transplantation of Cholangiocarcinoma

Robert R. McMillan et al.

Summary: Liver transplantation has become an effective treatment for cholangiocarcinoma, particularly for unresectable hilar cholangiocarcinoma. There is increasing evidence supporting the use of LT in select patients with intrahepatic cholangiocarcinoma, especially those with small tumors or favorable disease biology. Furthermore, discoveries in the biology of iCCA suggest that patients with certain genetic abnormalities may benefit from targeted therapies after LT.

CURRENT TRANSPLANTATION REPORTS (2021)

Review Gastroenterology & Hepatology

Liver resection and transplantation for intrahepatic cholangiocarcinoma

Vincenzo Mazzaferro et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Jesus M. Banales et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Anatomical, histomorphological and molecular classification of cholangiocarcinoma

Timothy Kendall et al.

LIVER INTERNATIONAL (2019)

Article Gastroenterology & Hepatology

Liver Transplant for Cholangiocarcinoma

Daniel Zamora-Valdes et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges

Ijin Joo et al.

RADIOLOGY (2018)

Review Oncology

Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates

Andrew J. Lee et al.

CHINESE CLINICAL ONCOLOGY (2018)

Article Gastroenterology & Hepatology

Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy

Xu-Feng Zhang et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2017)

Review Oncology

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma

Agrin Moeini et al.

CLINICAL CANCER RESEARCH (2016)

Article Gastroenterology & Hepatology

Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type

Shinichi Aishima et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)

Article Gastroenterology & Hepatology

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater et al.

JOURNAL OF HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?

Shahid A. Khan et al.

JOURNAL OF HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival

Caroline D. M. Witjes et al.

Article Gastroenterology & Hepatology

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany

Thomas von Hahn et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

R0 Liver Resections for Primary Malignant Liver Tumors in the Noncirrhotic Liver: A Diagnosis-Related Analysis

Georgios C. Sotiropoulos et al.

DIGESTIVE DISEASES AND SCIENCES (2009)

Article Gastroenterology & Hepatology

What prognostic factors are important for resected intrahepatic cholangiocarcinoma?

Kwang Yeol Paik et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period

Natasha S. Becker et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2008)